NCT07185672View on ClinicalTrials.gov

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

PHASE3RecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

August 7, 2019

Primary Completion Date

August 7, 2027

Study Completion Date

August 7, 2027

Conditions
Neuroendocrine Neoplasia's (NENs)Neuroendocrine Tumor GEP Grade 1-3Neuroendocrine Gastroenteropancreatic Tumour
Interventions
RADIATION

Peptide Receptor Radionuclide Therapy with Lu177 DOTATATE

Radionuclide Therapy

DRUG

Capecitabine plus temozolamide

Chemotherapy

Trial Locations (2)

400012

RECRUITING

Tata Memorial Hospital, Mumbai, India, Mumbai

410210

RECRUITING

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai

All Listed Sponsors
lead

Tata Memorial Hospital

OTHER_GOV